Douglas S. Ingram was appointed as President of Allergan. In this role, Mr. Ingram will lead the company's global commercial operations, with responsibility for the company's broad portfolio of pharmaceutical, consumer, and medical device products including facial aesthetics products such as BOTOX® Cosmetic and the JUVÉDERM® family of facial fillers and medical dermatology products such as ACZONE®. With more than 25 years of professional experience, Mr. Ingram has a strong background in the health care industry. For the past three years, Mr. Ingram has served as Executive Vice President and President, Europe, Africa and Middle East. Previously, Mr. Ingram served as Executive Vice President and Chief Administrative Officer. He also served as Allergan's Secretary and Chief Ethics Officer from July 2001 to July 2010. Mr. Ingram joined Allergan in 1996 as Senior Attorney and Chief Litigation Officer and was promoted to Associate General Counsel and Assistant Secretary, and later, to General Counsel. Before joining Allergan in 1996, Mr. Ingram was an attorney with Gibson, Dunn & Crutcher from 1988, practicing in the area of complex commercial litigation.